Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
UK HFpEF Collaborative Group
https://pubmed.ncbi.nlm.nih.gov/37827557/Actively Recruiting
Led by Manchester University NHS Foundation Trust · Updated on 2025-05-06
10000
Participants Needed
26
Research Sites
N/A
Total Duration
Heart failure with preserved ejection fraction HFpEF occurs when the hearts pumping function is normal but the heart cannot pump blood properly. This condition causes symptoms like breathlessness, swollen feet and ankles, and tiredness. HFpEF is complex and varies widely among patients, making it poorly understood with limited treatment options. The UK HFpEF study aims to improve understanding of why people develop HFpEF, create better diagnostic tests, identify new treatments, and follow participants health over many years. This observational study involves creating a large registry by collaborating across many centers in the UK. The registry will collect detailed information from thousands of patients with HFpEF, enabling researchers to classify the condition more precisely and develop personalized treatment approaches. This platform will support future research trials targeting specific patient groups and enable efficient patient recruitment. Participants will undergo detailed assessments including clinical evaluations, measurements of natriuretic peptide levels, and long-term health monitoring. Researchers will analyze data to identify distinct HFpEF subgroups, understand causes, and improve risk prediction over a 10-year period. This study is designed to provide important insights for better care and treatment strategies, with ongoing follow-up to track health outcomes.
CONDITIONS
UK Heart Failure With Preserved Ejection Fraction
F
Fardad Soltani, MBChB MRCP
L
Lucy Priestner
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Manchester University NHS Foundation Trust
Lead Sponsor
Pumping Marvellous Foundation
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants with heart failure with preserved ejection fraction (HFpEF) are observed and data are collected to better understand the condition and its subgroups over time.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
UK HFpEF Collaborative Group
https://pubmed.ncbi.nlm.nih.gov/37827557/Gavin A Lewis, Erik B Schelbert, Simon G Williams...
https://pubmed.ncbi.nlm.nih.gov/29050567/Scott D Solomon, John J V McMurray, Inder S Anand...
https://pubmed.ncbi.nlm.nih.gov/31475794/Theophilus E Owan, David O Hodge, Regina M Herges...
https://pubmed.ncbi.nlm.nih.gov/16855265/Bertram Pitt, Marc A Pfeffer, Susan F Assmann...
https://pubmed.ncbi.nlm.nih.gov/24716680/Manchester University NHS Foundation Trust
Lead Sponsor
Pumping Marvellous Foundation
Collaborating Sponsor